Compare · AAPL vs OMCL
AAPL vs OMCL
Side-by-side comparison of Apple Inc. (AAPL) and Omnicell Inc. (OMCL): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AAPL and OMCL operate in Computer Manufacturing (Technology), so they compete in similar markets.
- AAPL is the larger of the two at $4.90T, about 2349.7x OMCL ($2.09B).
- OMCL has been more active in the news (6 items in the past 4 weeks vs 5 for AAPL).
- AAPL has more recent analyst coverage (25 ratings vs 24 for OMCL).
- Company
- Apple Inc.
- Omnicell Inc.
- Price
- -
- -
- Market cap
- $4.90T
- $2.09B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Computer Manufacturing
- Computer Manufacturing
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 1980
- 2001
- News (4w)
- 5
- 6
- Recent ratings
- 25
- 24
Apple Inc.
Apple Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide. It also sells various related services. The company offers iPhone, a line of smartphones; Mac, a line of personal computers; iPad, a line of multi-purpose tablets; and wearables, home, and accessories comprising AirPods, Apple TV, Apple Watch, Beats products, HomePod, iPod touch, and other Apple-branded and third-party accessories. It also provides AppleCare support services; cloud services store services; and operates various platforms, including the App Store, that allow customers to discover and download applications and digital content, such as books, music, video, games, and podcasts. In addition, the company offers various services, such as Apple Arcade, a game subscription service; Apple Music, which offers users a curated listening experience with on-demand radio stations; Apple News+, a subscription news and magazine service; Apple TV+, which offers exclusive original content; Apple Card, a co-branded credit card; and Apple Pay, a cashless payment service, as well as licenses its intellectual property. The company serves consumers, and small and mid-sized businesses; and the education, enterprise, and government markets. It sells and delivers third-party applications for its products through the App Store. The company also sells its products through its retail and online stores, and direct sales force; and third-party cellular network carriers, wholesalers, retailers, and resellers. Apple Inc. was founded in 1977 and is headquartered in Cupertino, California.
Omnicell Inc.
Omnicell, Inc., together with its subsidiaries, provides medication management automation solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System, a building block of autonomous pharmacy vision; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. It also provides point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. In addition, the company provides automated systems to help pharmacies in filling its multimed adherence packaging based on individual patient medication orders; single dose automation solutions to fill and label for incoming prescriptions; semi-automated filling equipment for the long-term care institutional pharmacy; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.
Latest AAPL
- Apple upgraded by HSBC Securities with a new price target
- Apple downgraded by KeyBanc Capital Markets with a new price target
- Citigroup reiterated coverage on Apple with a new price target
- Apple scores record 89 Emmy Award nominations, with top category nods for celebrated comedies Widow’s Bay, Shrinking, and Margo’s Got Money Troubles, and global hit dramas Pluribus, Slow Horses, and Your Friends & Neighbors
- Apple to increase spend with Broadcom to produce billions more U.S. chips
- SVP, GC and Secretary Newstead Jennifer converted options into 30,104 shares and covered exercise/tax liability with 16,238 shares, increasing direct ownership by 50% to 41,546 units (SEC Form 4) to cover withholding tax
- Principal Accounting Officer Borders Ben converted options into 240 shares, covered exercise/tax liability with 124 shares and sold $34,236 worth of shares (116 units at $295.14) as part of a pre-agreed trading plan (SEC Form 4) to satisfy withholding obligation
- Apple accelerates app development with new intelligence frameworks and advanced tools
- Apple Intelligence brings powerful AI capabilities into everyday experiences
- Apple introduces Siri AI, a profoundly more capable and personal assistant
Latest OMCL
- CHAIRMAN, CEO Lipps Randall A sold $470,000 worth of shares (10,000 units at $47.00) as part of a pre-agreed trading plan (SEC Form 4)
- Omnicell to Release Second Quarter 2026 Financial Results on July 30, 2026
- SEC Form S-8 filed by Omnicell Inc.
- President & COO Njoku Nnamdi was granted 12,309 shares, increasing direct ownership by 8% to 167,094 units (SEC Form 4)
- Omnicell Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Nnamdi Njoku Appointed President of Omnicell
- Omnicell Selects Dan Mandoli to Lead Specialty Pharmacy Services Business
- Director Bousa Edward Peter was granted 4,603 shares, increasing direct ownership by 26% to 22,589 units (SEC Form 4)
- Director Scott Bruce E was granted 4,627 shares, increasing direct ownership by 20% to 27,600 units (SEC Form 4)
- Director Seim Robin Gene was granted 4,845 shares, increasing direct ownership by 10% to 52,198 units (SEC Form 4)